Personalized Breast Cancer Treatment

Faculty of Medicine / Department of Clinical Sciences, Lund / Section I / Breast cancer treatment

Personalized Breast Cancer Treatment's profile in Lund University Research portal

Description

Breast cancer is a heterogeneous disease with differences in clinical outcome and sensitivity to treatment. The choice of treatment after surgery (radiotherapy, antibodies, endocrine or chemo) is based on prognostic (risk of recurrence) and treatment predictive (choice of treatment) factors. About two thirds are cured after surgery, and still about 90% receive additional treatment. This means that some patients are over treated, but at the same time the treatment is lifesaving for others. It is extremely important to identify patients in need of additional treatment and, when needed, to choose the correct treatment. We are working towards new ways of looking at the information already collected and evaluated in the clinical routine but we’re also trying to identify new factors with both conventional techniques (e.g. immunohistochemistry) and new techniques (e.g. sequencing) that will help clinicians deciding what treatment or treatment combination will be best for the individual patient.

Coworkers

A

Sara Alkner

Research project participant

sara [dot] alkner [at] med [dot] lu [dot] se

B

Pär-Ola Bendahl

Research project participant

par-ola [dot] bendahl [at] med [dot] lu [dot] se

E

Maria Ekholm

Research project participant

maria [dot] ekholm [at] med [dot] lu [dot] se

F

Mårten Fernö

Project manager

marten [dot] ferno [at] med [dot] lu [dot] se
Carina Forsare

Research project participant

carina [dot] forsare [at] med [dot] lu [dot] se

L

Kristina Lövgren

Research project participant

kristina [dot] lovgren [at] med [dot] lu [dot] se

N

Ulrik Narbe

Research project participant

ulrik [dot] narbe [at] med [dot] lu [dot] se

S

Martin Sjöström

Research project participant

martin [dot] sjostrom [at] med [dot] lu [dot] se